(PharmaNewsWire.Com, May 31, 2019 ) According to the new market research report “Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) — Forecast”, published by MarketsandMarkets™,
The report segments the needle-free injection system market based on the product, technology, type, site of delivery, applications, end user and regions.
Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors, and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.
Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016. The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.
Browse and in-depth TOC on “Needle-Free Injection System Market”
151 — Tables
33 — Figures
183 — Pages
Based on region, the needle-free injection system market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada; while Europe is further subsegmented into Germany, France, the U.K. Italy, Spain, and Rest of Europe (RoE); Asia is further subsegmented into Japan, China, India and Rest of Asia (RoA).
North America is expected to dominate the market, followed by Europe. The increasing demand for self-administration, and rising prevalence of chronic diseases and conditions (such as heart disease, stroke, cancer, type 2 diabetes, obesity, and arthritis), advantages offer by needle-free injection system are driving market growth in North America.
The needle-free injection system market is a fragmented market, with several big and emerging players.Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
